Download PDF

Other users also viewed these articles

Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial Alvar Agusti; José Luis Lopez-Campos; Marc Miravitlles; Juan Jose Soler-Cataluña; Jose Maria Marin; Borja G. Cosio; Bernardino Alcázar-Navarrete; Jose Maria Echave-Sustaeta; Ciro Casanova; German Peces-Barba; Juan Pablo de-Torres; Alberto Fernandez-Villar; Julio Ancochea; Felipe Villar-Alvarez; Miguel Roman-Rodriguez; Jesus Molina; Juan Luis Garcia-Rivero; Cruz Gonzalez; Patricia Sobradillo; Rosa Faner; Carolina Peña; Raj Sharma; José Luis Izquierdo; Bartolome R. Celli;
Arch Bronconeumol. 2024;60:417-22
Biological Therapy in COPD Management: Current Evidence, Challenges and Opportunities Dave Singh; Antonio Menéndez Lobo; Andrew Higham; Bernardino Alcázar Navarrete;
Arch Bronconeumol. 2025;61:690-6
Clinical and Lung Microbiome Impact of Chronic Versus Intermittent Pseudomonas aeruginosa Infection in Bronchiectasis Laia Fernández-Barat; Ruben López-Aladid; Victoria Alcaraz-Serrano; Nil Vázquez; Leticia Bueno-Freire; Roque Pastor-Ibañez; Lena Lingren; Héctor Sanz-Fraile; Patricia Oscanoa; Ana Motos; Roberto Cabrera; Jordi Vila; Daniel Martínez; Jordi Otero; Ramon Farré; Niels Høiby; Antoni Torres;
Arch Bronconeumol. 2025;61:669-79